#CYTK↓

CYTK/ 12/19/2025 · 4:21 PM

FDA Approves New Heart Drug MYQORZO for Obstructive HCM

The FDA has approved Cytokinetics' MYQORZO (aficamten), a groundbreaking treatment for adults with symptomatic obstructive hypertrophic cardiomyopathy to improve heart function and reduce symptoms.

CYTK/ 09/02/2025 · 6:09 AM

Aficamten: A New Horizon for Hypertrophic Cardiomyopathy Treatment

Cytokinetics' experimental drug Aficamten demonstrates superior improvements in exercise capacity and cardiac function compared to standard care for obstructive hypertrophic cardiomyopathy, with a favorable safety profile across multiple studies.